Bradford Capital Partners

Cohera Medical, Inc. is a medical device company based in Raleigh, North Carolina, specializing in the development and sale of surgical adhesives and sealants for various surgical procedures. Founded in 2003, the company offers several innovative products, including TissuGlu, a biocompatible surgical adhesive designed for tissue approximation in abdominoplasty procedures, and Sylys, a surgical sealant aimed at reducing anastomotic leaks in gastrointestinal surgeries. TissuGlu is approved for use in the United States and the European Union, where it helps eliminate drains and reduce complications in large flap surgeries. Sylys has also received CE Mark approval in Europe for use in ileostomy reversal procedures. Cohera Medical continues to expand its product pipeline, which includes surgical mesh adhesives, hemostatic foams, and bone adhesives, addressing a broad range of surgical applications across various specialties such as plastic surgery, general surgery, and orthopedics.